Based on the results of CALGB 80803, would you consider induction and/or concurrent FOLFOX in neoadjuvant treatment of esophageal adenocarcinoma?   


Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at UT Southwestern Medical Center
Thank you for your input, experience, and dialogue...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice

Answer from: Radiation Oncologist at Community Practice

Answer from: Medical Oncologist at Academic Institution